Orkambi 125 mg

Orkambi 125 mg tablets contain ivacaftor, a medication used to treat cystic fibrosis. This oral medication is designed to improve lung function and reduce symptoms associated with the condition.

Orkambi 125 mg tablets are primarily used in the management of cystic fibrosis. Ivacaftor, the active ingredient, works by helping the CFTR protein function more effectively, which can improve lung function and reduce symptoms like coughing and shortness of breath. This medication is often prescribed as part of a comprehensive treatment plan for cystic fibrosis.

Common effects of Orkambi 125 mg tablets may include improvements in lung function and a reduction in symptoms such as coughing and shortness of breath. Some individuals may experience side effects, which can vary in severity and frequency. It is important to discuss any concerns with a healthcare provider.

Orkambi 125 mg tablets should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Orkambi 125 mg tablets may interact with certain medications, including those that are metabolized by the liver. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Additionally, alcohol and other substances may affect the efficacy of ivacaftor.